These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway. Wang MH, Sun R, Zhou XM, Zhang MY, Lu JB, Yang Y, Zeng LS, Yang XZ, Shi L, Xiao RW, Wang HY, Mai SJ. Cell Death Dis; 2018 Jan 05; 9(1):2. PubMed ID: 29305578 [Abstract] [Full Text] [Related]
3. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway. Zhou XM, Sun R, Luo DH, Sun J, Zhang MY, Wang MH, Yang Y, Wang HY, Mai SJ. Oncotarget; 2016 Mar 22; 7(12):13634-50. PubMed ID: 26872369 [Abstract] [Full Text] [Related]
4. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. Cai LM, Lyu XM, Luo WR, Cui XF, Ye YF, Yuan CC, Peng QX, Wu DH, Liu TF, Wang E, Marincola FM, Yao KT, Fang WY, Cai HB, Li X. Oncogene; 2015 Apr 23; 34(17):2156-66. PubMed ID: 25347742 [Abstract] [Full Text] [Related]
5. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells. Zhang P, Lu X, Shi Z, Li X, Zhang Y, Zhao S, Liu H. Gene; 2019 Aug 20; 710():103-113. PubMed ID: 31158447 [Abstract] [Full Text] [Related]
6. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC. Ke L, Xiang Y, Guo X, Lu J, Xia W, Yu Y, Peng Y, Wang L, Wang G, Ye Y, Yang J, Liang H, Kang T, Lv X. Oncotarget; 2016 May 10; 7(19):28340-55. PubMed ID: 27078847 [Abstract] [Full Text] [Related]
7. LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN. Gao Q, Tang L, Wu L, Li K, Wang H, Li W, Wu J, Li M, Wang S, Zhao L. Cell Death Dis; 2018 Mar 12; 9(3):393. PubMed ID: 29531214 [Abstract] [Full Text] [Related]
8. MiRNA-34a reversed TGF-β-induced epithelial-mesenchymal transition via suppression of SMAD4 in NPC cells. Huang G, Du MY, Zhu H, Zhang N, Lu ZW, Qian LX, Zhang W, Tian X, He X, Yin L. Biomed Pharmacother; 2018 Oct 12; 106():217-224. PubMed ID: 29960168 [Abstract] [Full Text] [Related]
9. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling. He QY, Yi HM, Yi H, Xiao T, Qu JQ, Yuan L, Zhu JF, Li JY, Wang YY, Li LN, Feng J, Lu SS, Xiao ZQ. Oncotarget; 2015 Jun 30; 6(18):16422-36. PubMed ID: 25915430 [Abstract] [Full Text] [Related]
10. The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu LJ, Kong QL, Xu LH, Zhang X, Liu WL, Li MZ, Zhang L, Kang TB, Fu LW, Huang WL, Xia YF, Tsao SW, Li M, Band V, Band H, Shi QH, Zeng YX, Zeng MS. J Clin Invest; 2009 Dec 30; 119(12):3626-36. PubMed ID: 19884659 [Abstract] [Full Text] [Related]
11. Deficiency of pigment epithelium-derived factor in nasopharyngeal carcinoma cells triggers the epithelial-mesenchymal transition and metastasis. Zhang T, Yin P, Zhang Z, Xu B, Che D, Dai Z, Dong C, Jiang P, Hong H, Yang Z, Zhou T, Shao J, Xu Z, Yang X, Gao G. Cell Death Dis; 2017 Jun 01; 8(6):e2838. PubMed ID: 28569772 [Abstract] [Full Text] [Related]
12. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL, Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY, Fu L. Carcinogenesis; 2013 Feb 01; 34(2):454-63. PubMed ID: 23125220 [Abstract] [Full Text] [Related]
13. Hes1 promotes cell proliferation and migration by activating Bmi-1 and PTEN/Akt/GSK3β pathway in human colon cancer. Gao F, Huang W, Zhang Y, Tang S, Zheng L, Ma F, Wang Y, Tang H, Li X. Oncotarget; 2015 Nov 17; 6(36):38667-80. PubMed ID: 26452029 [Abstract] [Full Text] [Related]
14. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition. Jiang H, Gao M, Shen Z, Luo B, Li R, Jiang X, Ding R, Ha Y, Wang Z, Jie W. Oncol Rep; 2014 Aug 17; 32(2):559-66. PubMed ID: 24889918 [Abstract] [Full Text] [Related]
15. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C, Shan Z, Hong J, Yang L. Int J Oncol; 2017 Jul 17; 51(1):235-244. PubMed ID: 28534966 [Abstract] [Full Text] [Related]
16. EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop. Yang CF, Yang GD, Huang TJ, Li R, Chu QQ, Xu L, Wang MS, Cai MD, Zhong L, Wei HJ, Huang HB, Huang JL, Qian CN, Huang BJ. Oncogene; 2016 Jun 30; 35(26):3419-31. PubMed ID: 26568302 [Abstract] [Full Text] [Related]
17. Inhibition of ZIP4 reverses epithelial-to-mesenchymal transition and enhances the radiosensitivity in human nasopharyngeal carcinoma cells. Zeng Q, Liu YM, Liu J, Han J, Guo JX, Lu S, Huang XM, Yi P, Lang JY, Zhang P, Wang CT. Cell Death Dis; 2019 Aug 05; 10(8):588. PubMed ID: 31383854 [Abstract] [Full Text] [Related]
18. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling. Liu Y, Liu Q, Chen S, Liu Y, Huang Y, Chen P, Li X, Gao G, Xu K, Fan S, Zeng Z, Xiong W, Tan M, Li G, Zhang W. FASEB J; 2019 Nov 05; 33(11):11959-11972. PubMed ID: 31408612 [Abstract] [Full Text] [Related]
19. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway. Hu W, Xiao L, Cao C, Hua S, Wu D. Oncotarget; 2016 Mar 22; 7(12):15161-72. PubMed ID: 26943030 [Abstract] [Full Text] [Related]
20. Glutaredoxin 3 promotes nasopharyngeal carcinoma growth and metastasis via EGFR/Akt pathway and independent of ROS. He F, Wei L, Luo W, Liao Z, Li B, Zhou X, Xiao X, You J, Chen Y, Zheng S, Li P, Murata M, Huang G, Zhang Z. Oncotarget; 2016 Jun 14; 7(24):37000-37012. PubMed ID: 27203742 [Abstract] [Full Text] [Related] Page: [Next] [New Search]